Dr. Reddy’s Q3 and 9M FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51
February 9, 2016 7:22 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.51, versus $0.51 reported last year. Revenue for the quarter came in at $599 million, versus $581 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More